标题
Transglutaminase mediated PEGylation of nanobodies for targeted nano-drug delivery
作者
关键词
-
出版物
Journal of Materials Chemistry B
Volume 6, Issue 7, Pages 1011-1017
出版商
Royal Society of Chemistry (RSC)
发表日期
2018-01-17
DOI
10.1039/c7tb03132g
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nanobodies: Chemical Functionalization Strategies and Intracellular Applications
- (2018) Dominik Schumacher et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nanobody Technology: A Versatile Toolkit for Microscopic Imaging, Protein–Protein Interaction Analysis, and Protein Function Exploration
- (2017) Els Beghein et al. Frontiers in Immunology
- In vivo covalent cross-linking of photon-converted rare-earth nanostructures for tumour localization and theranostics
- (2016) Xiangzhao Ai et al. Nature Communications
- Anticancer drug delivery systems based on specific interactions between albumin and polyglycerol
- (2016) Zahra Beiranvand et al. RSC Advances
- A dual-fluorescent nano-carrier for delivering photoactive ruthenium polypyridyl complexes
- (2016) Hongdong Shi et al. Journal of Materials Chemistry B
- Site-Specific PEGylation of Therapeutic Proteins
- (2015) Jonathan Dozier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis
- (2015) José L. Arias et al. JOURNAL OF CONTROLLED RELEASE
- Nanobody-based cancer therapy of solid tumors
- (2015) Marta Kijanka et al. Nanomedicine
- Site-Specific Labeling of Cysteine-Tagged Camelid Single-Domain Antibody-Fragments for Use in Molecular Imaging
- (2014) Sam Massa et al. BIOCONJUGATE CHEMISTRY
- Process for protein PEGylation
- (2014) David Pfister et al. JOURNAL OF CONTROLLED RELEASE
- Therapeutic Protein–Polymer Conjugates: Advancing Beyond PEGylation
- (2014) Emma M. Pelegri-O’Day et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
- (2013) Pavel Strop et al. CHEMISTRY & BIOLOGY
- Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains
- (2013) Karl R. Schmitz et al. STRUCTURE
- Monosaccharides versus PEG-Functionalized NPs: Influence in the Cellular Uptake
- (2012) María Moros et al. ACS Nano
- In Vitro and In Vivo Uncaging and Bioluminescence Imaging by Using Photocaged Upconversion Nanoparticles
- (2012) Yanmei Yang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy
- (2012) Marina Talelli et al. BIOMATERIALS
- Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells
- (2012) Isil Altintas et al. JOURNAL OF CONTROLLED RELEASE
- Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects
- (2012) J. A. J. M. van de Water et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protein Lipidation Catalyzed by Microbial Transglutaminase
- (2011) Hiroki Abe et al. CHEMISTRY-A EUROPEAN JOURNAL
- A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth
- (2011) Rob C. Roovers et al. INTERNATIONAL JOURNAL OF CANCER
- HSA Coated Iron Oxide Nanoparticles as Drug Delivery Vehicles for Cancer Therapy
- (2011) Qimeng Quan et al. MOLECULAR PHARMACEUTICS
- EGFR Signaling and Drug Discovery
- (2010) Georg Lurje et al. ONCOLOGY
- Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase
- (2007) Angelo Fontana et al. ADVANCED DRUG DELIVERY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now